Here are relevant reports on : synthetic-biology-market
-
Synthetic Biology Market by Tools (Oligonucleotides, Enzymes, Synthetic Cells), Technology (Sequencing, Bioinformatics), Applications (Drug Discovery, Tissue Regeneration, Biofuel, Food, Agriculture, Consumer Care, Environmental) - Global Forecast to 2029
The global synthetic biology market, valued at US$11.97 billion in 2023, stood at US$12.33 billion in 2024 and is projected to advance at a resilient CAGR of 20.6% from 2024 to 2029, culminating in a forecasted valuation of US$31.52 billion by the end of the period. Some of the prominent factors driving the growth of the market include the rising demand for bio-based products, increased funding in R&D, and collaborations.
- Published: November 2024
- Price: $ 4950
- TOC Available:
-
Molecular Biology Enzymes Market by Product (Kits, Reagents, Enzyme), Application (PCR, Sequencing, Epigenetic, Synthetic Biology), End user (Research Institutes, Pharma & Biotech Company, Hospitals) and Region - Global Forecast to 2026
The global molecular biology enzymes market in terms of revenue was estimated to be worth $15.3 billion in 2021 and is poised to reach $29.7 billion by 2026, growing at a CAGR of 14.2% from 2021 to 2026. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: May 2021
- Price: $ 4950
- TOC Available:
-
Ligase Enzymes Market by Type (DNA, RNA), Source (Viral, Bacterial, Eukaryotic), Grade (RUO, GMP, Diagnostic), Molecular Biology Workflow (Cloning, Sequencing, Synthetic Biology), Application (Research, Diagnostic, Therapeutic) - Global Forecast 2030
The global ligase enzymes market, valued at US$0.25 billion in 2024, stood at US$0.26 billion in 2025 and is projected to advance at a resilient CAGR of 6.8% from 2025 to 2030, culminating in a forecasted valuation of US$0.36 billion by the end of the period. The ligase enzymes market is growing due to the rising demand for molecular diagnostics, the increasing adoption of next-generation sequencing (NGS), expanding applications in synthetic biology, and continuous advancements in enzyme engineering.
- Published: September 2025
- Price: $ 4950
- TOC Available:
-
Laser Capture Microdissection Market by Product (Instruments, Consumables, Software, Services), System Type (Ultraviolet, Infrared, Immunofluorescence), Application (R&D (Molecular Biology, Cell Biology, Forensics), Diagnostics) & Region - Global Forecast to 2029
The global laser capture microdissection market, valued at US$176 million in 2023, stood at US$184 million in 2024 and is projected to advance at a resilient CAGR of 10.6% from 2024 to 2029, culminating in a forecasted valuation of US$306 million by the end of the period. The growth of this market is majorly driven by the rising pace of R&D and growing expenditure. On the other hand, requirement of high degree of technical expertise is a major factor restraining market growth to a certain extent.
- Published: March 2024
- Price: $ 4950
- TOC Available:
-
Asia Pacific Epigenetics Market by Offering [Enzymes, Kits & Reagents, Software, Services], Method [DNA Methylation, Histone Modification], Technique [NGS, PCR], Application [Oncology, Immunology, Developmental Biology], End User - Forecast to 2030
The Asia Pacific epigenetics market is projected to reach USD 0.97 billion by 2030 from USD 0.49 billion in 2025, at a CAGR of 14.6% during the forecast period of 2025 to 2030. The Key Players include Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Illumina, Inc. (US), QIAGEN (Germany), along with other regional and global companies.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Asia Pacific Epigenetics Market by Offering [Enzymes, Kits & Reagents, Software, Services], Method [DNA Methylation, Histone Modification], Technique [NGS, PCR], Application [Oncology, Immunology, Developmental Biology], End User - Forecast to 2030
The Asia Pacific epigenetics market is projected to reach USD 0.97 billion by 2030 from USD 0.49 billion in 2025, at a CAGR of 14.6% during the forecast period of 2025 to 2030. The Key Players include Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Illumina, Inc. (US), QIAGEN (Germany), along with other regional and global companies.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Europe Epigenetics Market by Product & Service [Enzymes, Kits & Reagents (Antibodies), Software], Method [DNA Methylation, Histone Modification], Technique [NGS, PCR], Application [Oncology, Immunology, Developmental Biology], End User - Forecast to 2030
The Europe epigenetics market, valued at USD 0.57 billion in 2024, stood at USD 0.63 billion in 2025 and is projected to advance at a resilient CAGR of 14.1% from 2025 to 2030, culminating in a forecasted valuation of USD 1.22 billion by the end of the period. Growth is supported by a well-funded life sciences ecosystem, with rising oncology and precision medicine programs that increasingly rely on DNA methylation and chromatin profiling for biomarker discovery and translational research.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Epigenetics Market by Product & Service (Enzymes, Kits & Reagents (Antibodies), Software), Method (DNA Methylation, Histone Modification), Technique (NGS, PCR), Application (Oncology, Immunology, Developmental Biology), End User - Global Forecast to 2030
The global epigenetics market, valued at US$2.03 billion in 2024, stood at US$2.24 billion in 2025 and is projected to advance at a resilient CAGR of 11.3% from 2025 to 2030, culminating in a forecasted valuation of US$4.29 billion by the end of the period. The major factors driving the growth in epigenetics market includes reduced sequencing costs and accelerated turnaround times to improve access and affordability of epigenetic analysis.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
North America Epigenetics Market by Product & Service [Enzymes, Kits & Reagents (Antibodies), Software], Method [DNA Methylation, Histone Modification], Technique [NGS, PCR], Application [Oncology, Immunology, Developmental Biology]-Forecast to 2030
The North America epigenetics market, valued at USD 0.84 billion in 2024, stood at USD 0.93 billion in 2025 and is projected to advance at a resilient CAGR of 13.8% from 2025 to 2030, culminating in a forecasted valuation of USD 1.78 billion by the end of the period. Growth of the North America epigenetics market is driven by a strong, well-funded life sciences ecosystem, with rising oncology and precision-medicine programs that rely on methylation and chromatin profiling.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Track Etched Membrane Market by Product (Membrane Filter, Capsule & Cartridge Filter, Cell Culture Insert), Material (Polycarbonate, Polyimide), Application (Cell Biology, Microbiology, Analytical testing, Automotive), End User - Global Forecasts to 2023
The track etched membrane market is projected to reach USD 813.1 million by 2023, growing at a CAGR of 11.3%. Key players operating in the global track etched membrane are GE Healthcare (US), Danaher (US), Corning (US), Merck (Germany), it4ip (Belgium), Sterlitech (US), Oxyphen (Switzerland), Sarstedt (US), BRAND GMBH (Germany), Sartorius (Germany), SABEU (Germany), Zefon International (US), GVS (Italy), Thermo Fisher Scientific (US), Eaton (Ireland), Greiner Bio-One (Austria), MACHEREY-NAGEL (Germany), Avanti Lipids Polar (US), SKC (US), Advantec (Canada), Avestin (Canada), Scaffdex (Finland), and Graver Technologies (US).
- Published: September 2018
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
